Skip to main content
Clinical Trials/NCT06537687
NCT06537687CompletedNot Applicable

Relational Agents in Cervical Cancer Education (RACE)

Radhika Gogoi2 sites in 1 country91 target enrollmentStarted: November 18, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
91
Locations
2
Primary Endpoint
Participation Rate

Study Overview

Brief Summary

The goal of this clinical trial is to assess the feasibility of using interactive teaching to educate cervical cancer patients about Human papillomavirus (HPV) and HPV vaccinations.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults aged 18 and older
  • •Patients with an ICD9 diagnosis of cervical/vaginal/vulvar cancer or dysplasia receiving care at Karmanos Cancer Institute or OU Health Stephenson Cancer Center

Exclusion Criteria

  • •Patients who are recorded in the EHR as requesting to be removed from research
  • •Non-English speakers
  • •Any cognitive disability that prevents informed consent
  • •Any individual recruited in previous phases of the Study will be excluded.

Arms & Interventions

Control

Active Comparator

The control group will be given a standardized handout

Intervention: Control (Other)

Intervention

Experimental

The intervention group will be shown an educational video

Intervention: Intervention (Other)

Outcomes

Primary Outcomes

Participation Rate

Time Frame: Up to 6 weeks

The Ratio of the number of participants to the number of patients asked to join the clinical trial

Survey Completion Rate

Time Frame: Up to 6 Weeks

The Ratio of the number of participants who complete the survey to the number of participants overall.

Secondary Outcomes

  • Change in intention to discuss HPV vaccination(Up to 6 weeks)
  • Change in social norms and behaviors(Up to 6 weeks)
  • Change in Stigma(Up to 6 weeks)
  • Change in Health Literacy(Up to 6 weeks)

Investigators

Sponsor
Radhika Gogoi
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Radhika Gogoi

Principal Investigator, Associate Professor

Barbara Ann Karmanos Cancer Institute

Study Sites (2)

Loading locations...

Similar Trials